[68]Ga-HA-DOTATATE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68]Ga-HA-DOTATATE, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use [Phase 1, Phase 2]